Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alzheimer's disease psychosis
Alzheimer's disease psychosis
Psychosis: The Other Big Alzheimer’s Therapeutic Target
BioSpace
Tue, 04/2/24 - 11:46 am
Alzheimer's disease
Alzheimer's disease psychosis
Cerevel Therapeutics
Karuna Therapeutics
Acadia hits another Nuplazid roadblock as the FDA doles out CRL and recommends another trial
Endpoints
Fri, 08/5/22 - 10:51 am
Acadia Pharmaceuticals
Nuplazid
FDA
complete response letter
Alzheimer's disease psychosis
A year after CRL, Acadia is going back to bat for Nuplazid at the FDA
Endpoints
Mon, 05/2/22 - 06:15 pm
Acadia Pharmaceuticals
FDA
Nuplazid
Alzheimer's disease psychosis
FDA panel to review once-rejected Acadia drug for psychosis
BioPharma Dive
Thu, 03/10/22 - 10:23 pm
Acadia Pharmaceuticals
FDA
Nuplazid
Alzheimer's disease psychosis
Acadia slims Nuplazid label expansion bid in hopes of clinching Alzheimer's dementia nod without extra studies
Fierce Pharma
Tue, 12/21/21 - 10:18 am
Acadia Pharmaceuticals
Nuplazid
dementia
Alzheimer's disease psychosis
